WHAT IS BORDETELLA PERTUSSIS TEST?

WHAT IS BORDETELLA PERTUSSIS TEST?

Pertussis is a highly communicable, acute bacterial infection of the tracheobronchial tree caused by Bordetella pertussis, a gram-negative coccobacillus. The disease occurs commonly in children throughout the world and can be prevented in 99.8% of cases by vaccination of 3 doses of DTaP (diphtheria, tetanus, and acellular pertussis) vaccine. Mode of transmission is believed to be either by direct contact with the respiratory discharges of infected clients or by inhalation of airborne droplets. It is most communicable in the early stages before the paroxysmal cough appears. Pertussis is characterised by an explosive cough followed by a “whooping” sound on inspiration and may include respiratory distress and apnea as symptoms. Pertussis can lead to CNS encephalopathy and pulmonary hypertension, and there are known cases of reinfection up to 12 years after initial diagnosis. 

 

KNOWLEDGE BASE
About Genomic Medicine UK

Genomic Medicine UK is the home of comprehensive genomic testing in London. Our consultant medical doctors work tirelessly to provide the highest standards of medical laboratory testing for personalised medical treatments, genomic risk assessments for common diseases and genomic risk assessment for cancers at an affordable cost for everybody. We use state-of-the-art modern technologies of next-generation sequencing and DNA chip microarray to provide all of our patients and partner doctors with a reliable, evidence-based, thorough and valuable medical service.

X